首页> 外文期刊>Cancer science. >Significance of integrin vβ5 and erbB3 in enhanced cell migration and liver metastasis of colon carcinomas stimulated by hepatocyte-derived heregulin
【24h】

Significance of integrin vβ5 and erbB3 in enhanced cell migration and liver metastasis of colon carcinomas stimulated by hepatocyte-derived heregulin

机译:整联蛋白vβ5和erbB3在肝细胞源性调蛋白刺激的结肠癌细胞迁移和肝转移中的作用

获取原文
       

摘要

To study the mechanisms of the highly liver-metastatic character of colon carcinoma cells, we studied the expression pattern of surface integrins on LS-LM6 (a highly liver-metastatic human colon cancer cell line) and the effects of hepatocyte-derived soluble factors on cell migration. LS-LM6 showed significantly higher expression of integrin vβ5, a ligand for vitronectin (VN), as compared with its parental cell line (LS174T). A conditioned medium of cultured mouse hepatocytes enhanced VN-mediated cell migration of LS-LM6, which was blocked by neutralizing antibody against integrin vβ5, while the medium did not affect cell adhesion to VN-coated plastic surfaces. The conditioned medium induced phosphorylation of erbB3 and its heterodimeric partner, erbB2. Heregulin (HRG), a ligand for erbB3, exerted similar effects on VN-mediated cell migration and phosphorylation of erbB3 and erbB2. The conditioned medium contained HRG, and depletion of HRG from the medium by pre-absorption with HRG antibody abolished its effects on cell migration. Heregulin (HRG) was expressed in some hepatocytes in the liver with carcinoma cell metastasis. Furthermore, knockdown of integrin v and erbB3 by small-interfering RNAs significantly inhibited cell migration induced by HRG as well as liver metastasis in vivo. Finally, we found that HRG-induced cell migration was associated with marked phosphorylation of Akt and that cell migration was suppressed by treatment with specific inhibitors of phosphatidylinositol 3-kinase. Our study suggests that hepatocyte-derived HRG might participate in a highly liver-metastatic phenotype of LS-LM6 through enhancement of integrin vβ5-mediated cell migration and erbB3/erbB2 signaling. (Cancer Sci 2010).
机译:为了研究结肠癌细胞高度肝转移的机制,我们研究了表面整合素在LS-LM6(一种高度肝转移人类结肠癌细胞系)上的表达模式以及肝细胞衍生的可溶性因子对肝癌细胞的影响。细胞迁移。与亲本细胞系(LS174T)相比,LS-LM6的整合素vβ5(玻连蛋白(VN)的配体)的表达明显更高。培养的小鼠肝细胞的条件培养基可增强VN介导的LS-LM6细胞迁移,该迁移被中和针对整联蛋白vβ5的抗体所阻断,而该培养基不会影响细胞对VN涂层塑料表面的粘附。条件培养基诱导erbB3及其异源二聚体erbB2磷酸化。 heregulin(HRG),erbB3的配体,对VN介导的细胞迁移和erbB3和erbB2的磷酸化具有相似的作用。条件培养基含有HRG,通过用HRG抗体预吸收从培养基中去除HRG消除了其对细胞迁移的影响。 Heregulin(HRG)在具有癌细胞转移的肝脏中的一些肝细胞中表达。此外,通过小干扰RNA敲低整联蛋白v和erbB3可以显着抑制HRG诱导的​​细胞迁移以及体内肝转移。最后,我们发现HRG诱导的​​细胞迁移与Akt的磷酸化显着相关,并且通过用磷脂酰肌醇3激酶的特定抑制剂治疗抑制了细胞迁移。我们的研究表明,肝细胞来源的HRG可能通过增强整合素vβ5介导的细胞迁移和erbB3 / erbB2信号传导而参与LS-LM6的高度肝转移表型。 (Cancer Sci 2010)。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号